Novel process allows ‘highest quality’ omega-3 concentrations

Novel technology allows KD-Pharma, the fully-owned subsidiary of health care products company Bioseutica, to produce what it claims to be the market’s safest and highest quality omega-3 concentrations.

Specific combinations of omega-3 EPA/DHA at concentrations of up to 99 percent are produced by the process, known as kd pür, which was designed, developed and patented the company.

This is achieved by advanced super critical fluid technology conducted under mild temperatures below 45 Celsius and under CO2 atmospheric conditions to extract, refine and concentrate highly purified omega-3s from fish oil.

The process is also said to remove other undesired components from omega-3s such as omega-6, saturated fats, cholesterol and contaminants.

More info